Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921
Journal of Clinical Oncology2023cited by 14position: middledoi
Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade glioma